Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remdesivir post-exposure prophylaxis for Ebola virus exposure
jRCTs031240115Recruiting
- Sponsor
- Health and Labour Sciences Research Grants
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of remdesivir in Ebola virus disease (EVD), sponsored by Health and Labour Sciences Research Grants. Started Jun 2024; status: recruiting.
02
Drugs
remdesivir
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on jRCTs031240115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240115.